Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J V McMurray

Showing results (1-10 of 1,140) with videos related to

Pageof 114
Sort By:
Nature Reviews. Cardiology|January 26, 2012
Heart failure in 2011: Heart failure therapy--technology to the foreJohn J V McMurray
Journal of Cardiac Failure|March 10, 2004
What are the clinical consequences of anemia in patients with chronic heart failure?John J V McMurray
European Journal of Heart Failure|March 11, 2015
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chancesJohn J V McMurray
European Journal of Heart Failure|August 6, 2011
CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failureJohn J V McMurray
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Angiotensin inhibition in heart failureJohn J V McMurray
Heart (British Cardiac Society)|January 20, 2005
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?E O'Meara, J J V McMurray
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Angiotensin receptor blockers in heart failureJan Stergren, John J V McMurray
European Journal of Heart Failure|March 11, 2021
Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fractionMilton Packer, John J V McMurray
Heart (British Cardiac Society)|April 16, 2005
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarctionR Weir, J J V McMurray
Lancet (London, England)|December 7, 2016
Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failureMilton Packer, John J V McMurray
Pageof 114

Showing results (1-10 of 1,140) with videos related to

Sort By:
Pageof 114
Nature Reviews. Cardiology|January 26, 2012
Heart failure in 2011: Heart failure therapy--technology to the foreJohn J V McMurray
Journal of Cardiac Failure|March 10, 2004
What are the clinical consequences of anemia in patients with chronic heart failure?John J V McMurray
European Journal of Heart Failure|March 11, 2015
Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chancesJohn J V McMurray
European Journal of Heart Failure|August 6, 2011
CONSENSUS to EMPHASIS: the overwhelming evidence which makes blockade of the renin-angiotensin-aldosterone system the cornerstone of therapy for systolic heart failureJohn J V McMurray
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 5, 2004
Angiotensin inhibition in heart failureJohn J V McMurray
Heart (British Cardiac Society)|January 20, 2005
Myocardial metabolic manipulation: a new therapeutic approach in heart failure?E O'Meara, J J V McMurray
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 11, 2003
Angiotensin receptor blockers in heart failureJan Stergren, John J V McMurray
European Journal of Heart Failure|March 11, 2021
Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fractionMilton Packer, John J V McMurray
Heart (British Cardiac Society)|April 16, 2005
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarctionR Weir, J J V McMurray
Lancet (London, England)|December 7, 2016
Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failureMilton Packer, John J V McMurray
Pageof 114